International Journal of Clinical Medicine
Vol.6 No.6(2015), Paper ID 56912, 5
pages
DOI:10.4236/ijcm.2015.66048
Clinical Utility of Procalcitonin for Differentiating between Cryptogenic Organizing Pneumonia and Community-Acquired Pneumonia
Satoshi Takeda, Nobuhiko Nagata, Hiroyuki Miyazaki, Takanori Akagi, Taishi Harada, Masaru Kodama, Shinichiro Ushijima, Takashi Aoyama, Kentaro Wakamatsu, Masaki Fujita, Kentaro Watanabe
Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan
Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan
Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan
Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan
Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan
Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan
Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan
Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan
Department of Respiratory Medicine, National Hospital Organization Omuta Hospital, Omuta, Japan
Department of Respiratory Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
Department of Respiratory Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
Copyright © 2015 Satoshi Takeda, Nobuhiko Nagata, Hiroyuki Miyazaki, Takanori Akagi, Taishi Harada, Masaru Kodama, Shinichiro Ushijima, Takashi Aoyama, Kentaro Wakamatsu, Masaki Fujita, Kentaro Watanabe et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Takeda, S. , Nagata, N. , Miyazaki, H. , Akagi, T. , Harada, T. , Kodama, M. , Ushijima, S. , Aoyama, T. , Wakamatsu, K. , Fujita, M. and Watanabe, K. (2015) Clinical Utility of Procalcitonin for Differentiating between Cryptogenic Organizing Pneumonia and Community-Acquired Pneumonia.
International Journal of Clinical Medicine,
6, 372-376. doi:
10.4236/ijcm.2015.66048.